Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Publication

Article

March 12, 2013

CURE

Spring 2013
Volume12
Issue 1

Managing Cancer-Related Fatigue

Author(s):

Barbara Sadick

Many patients feel sick and tired from treatment and their cancer, but there are ways to manage it.

Fatigue is the most common side effect of cancer and its treatment, and it varies in degree from patient to patient. It can be sporadic or constant, and, in some cases, is more intense and debilitating than “normal” fatigue. At its most intense, it can’t be relieved by sleep and is often described as “paralyzing.” It affects physical, emotional and social quality of life and is characterized by a lack of energy and motivation, total body exhaustion, a feeling of heaviness, an inability to concentrate or remember, and anxiety. Patients should discuss fatigue with their healthcare providers, who can suggest coping mechanisms and solutions, and can help them understand that such exhaustion doesn’t necessarily mean the cancer has worsened or recurred.

Fatigue is experienced by up to 90 percent of cancer patients and is caused by side effects of cancer treatments or by the cancer itself. Like the fatigue, causes vary from person to person and are often due to metabolic changes. Some cancers increase the body’s need for energy, weaken muscles and alter hormone levels. Others release proteins called cytokines, which appear to increase fatigue.

Little is known about cancer-related fatigue, but one cause may be the destruction of healthy cells in addition to those targeted for treatment and the amount of energy needed to repair and heal damaged tissues. Anemia, nausea, vomiting, pain, insomnia and mood change often occur during and after treatment and can lead to extreme fatigue.

The following are common causes of fatigue:

>

Chemotherapy, radiation, bone marrow transplantation and surgery, particularly chemotherapies that stop bone marrow from making enough red blood cells to carry oxygen to the body;

>

Biologic therapies that use the body’s immune system to fight cancer;

>

Treatment-related hormonal changes to thyroid and adrenal glands, testes and ovaries;

>

Treatment-related nutrient deficiencies;

>

Sleep disorders, anxiety, depression and difficulty learning and remembering (attention fatigue); and

>

Medication to treat other conditions and side effects, especially pain.

Following cancer treatment, most survivors want to resume a lifestyle free from cancer-related fatigue. The American Cancer Society estimates, though, that 30 to 50 percent of cancer survivors experience persistent fatigue for months and, sometimes years. It’s important to continue to consult with physicians, as underlying medical conditions that exacerbate the problem can often be treated. While more research is needed in this area, the following are some ways in which symptoms of fatigue can be managed:

>

Medications: Stimulants, such as Ritalin (methylphenidate) and modafinil, might help but must be prescribed and monitored by a physician.

>

Diet and Nutrition: Small, well-balanced, highprotein meals can provide energy. Ample fluid and limited caffeine and alcohol intake may prevent dehydration.

>

Exercise: Regular exercise routines can increase energy levels, lower blood pressure, improve the ability of the heart to pump blood and increase endurance. Evidence indicates that aerobic exercise, such as walking, cycling or swimming, can help alleviate fatigue.

>

Sleep and Relaxation: Sleep quality can be improved by practicing relaxation exercises before sleep, avoiding long afternoon naps and setting (and keeping) a sleep schedule.

>

Complementary Therapies: Acupuncture can reduce pain and nausea by increasing the body’s blood flow and natural painkillers. Practicing visual guided imagery, meditation and mind/body exercises, such as qigong, tai chi and yoga, can also help.

Articles in this issue

Qigong could reduce depression in patients with breast cancer undergoing radiation
How Caregivers Adjust to Post-Cancer Life
HPV-Related Cancers Rising
Planning for an Unpredictable Cancer
Pipeline
Research Updates
Stars Team Up to Help Young Cancer Patient
Tool Helps Users Prepare for End-of-Life Discussion
National Women's Survivors Convention
Dr. Lacouture's Skin Care Guide for People Living with Cancer
Recalcitrant Cancer Research Act Becomes Law
Weighing the Consequences
Meet the Team
Sarcoma in the Young
Preparing for Chemoradiotherapy

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.